SCHEMBL5731373

SCHEMBL5731373

Cc1nc(N)c2nc(O)n(Cc3ccc(Cl)cc3)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 6/20 0.42
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PDE8B O95263 1/20 0.40
POLB P06746 2/20 0.39
MAPT P10636 1/20 0.39
TNF P01375 1/20 0.39
CXCL8 P10145 1/20 0.39
SOS1 Q07889 1/20 0.39
NOD2 Q9HC29 1/20 0.39
NOD1 Q9Y239 1/20 0.39
GALR3 O60755 1/20 0.39
NR2F2 P24468 1/20 0.39
RAB9A P51151 1/20 0.39
VDR P11473 1/20 0.39
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5730974 0.90 TLR7 (0.43) TLR7KDM4EALDH1A1HPGDMAPT
SCHEMBL5731691 0.90 TLR7 (0.43) TLR7KDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL5730944 0.88 TLR7 (0.55) TLR7KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5731860 0.86 TLR7 (0.43) TLR7MEN1KMT2ATYMS
SCHEMBL5730510 0.86 TLR7 (0.47) TLR7KDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL5731978 0.86 KDM4E (0.47) TLR7KDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL5731748 0.86 CCR9 (0.42) TLR7SMN1; SMN2POLBMEN1KMT2A
SCHEMBL10309737 0.85 TLR7 (0.44) TLR7KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5731082 0.84 SMN1; SMN2 (0.52) KDM4ESMN1; SMN2ALDH1A1POLBMAPT
SCHEMBL5731513 0.83 L3MBTL1 (0.50) TLR7KDM4ESMN1; SMN2POLBNR2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1043021-B1 PURINE DERIVATIVES FOR THE TREATMENT OF ALLERGIC DISEASES AND SYSTEMIC LUPUS ERYTHEMATOSUS DAINIPPON SUMITOMO PHARMA CO (JP) 2006-05-03 EP disclosed
EP-0882727-B9 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2005-06-15 EP disclosed
EP-0882727-B1 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2004-12-01 EP disclosed
US-6376501-B1 INHIBITING OR REGULATING IMMUNE RESPONSE USING PURINE-DERIVED COMPOUND; NON-STEROIDAL COMPOUND JAPAN ENERGY CORPORATION (JP) 2002-04-23 US disclosed
EP-1043021-A1 TYPE 2 HELPER T CELL-SELECTIVE IMMUNE RESPONSE SUPPRESSORS Japan Energy Corporation (JP) 2000-10-11 EP disclosed
US-6028076-A FOR INDUCING .ALPHA.-INTERFERON IN A PATIENT HAVING HEPATITIS B OR C, BY ADMINISTERING PURINE DERIVATIVE JAPAN ENERGY CORPORATION (JP) 2000-02-22 US disclosed
EP-0882727-A1 NOVEL PURINE DERIVATIVES JAPAN ENERGY CORPORATION (JP) 1998-12-09 EP disclosed